Doç. Dr. Hacer Berna AFACAN ÖZTÜRK

1. Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project

PINAR İ. E., ÇELİK S., Polat M. G., Karatas A. F., DOĞAN A. A., ILTAR U., et al.

BMC Cancer , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

2. Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry †

KARAKUŞ V., PINAR İ. E., ILTAR U., Yenihayat E. M., Polat M. G., ÇELİK S., et al.

Journal of Clinical Medicine , cilt.14, sa.20, 2025 (SCI-Expanded, Scopus)

3. Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

Küçükyurt S., Koca O., TERZİ DEMİRSOY E., AKIN S., DOĞAN A. A., Gören D., et al.

Annals of Hematology , cilt.104, sa.9, ss.4679-4690, 2025 (SCI-Expanded, Scopus)

4. Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study

Sahin D., Soyer N., Yeral M., NAMDAROĞLU S., HİNDİLERDEN F., Aydogdu I., et al.

Nigerian Journal of Clinical Practice , cilt.28, sa.5, ss.602-607, 2025 (SCI-Expanded, Scopus)

5. Novel mutated Dubin–Johnson syndrome diagnosed during acute promyelocytic leukemia treatment

AFACAN ÖZTÜRK H. B., ALBAYRAK M., Reis Aras M., Yılmaz F., Düzkale N.

Memo - Magazine of European Medical Oncology , cilt.18, sa.2, ss.125-128, 2025 (ESCI, Scopus)

6. Clinical characteristics and outcomes in Epstein–Barr virus-positive diffuse large B-cell lymphoma: a multicenter retrospective study

Kiliç Güneş E., AFACAN ÖZTÜRK H. B., Kiriktir E., Dikyar A., Uğur B., GÜNEŞ A. K., et al.

Turkish Journal of Medical Sciences , cilt.55, sa.5, ss.1113-1121, 2025 (SCI-Expanded, Scopus, TRDizin)

7. Clinical Outcomes and Prognostic Factors in AML with Hyperleukocytosis: A Multicenter Real-World Study

Kilic Gunes E., Savas E. M., Erdogdu B., Gorduk U., Gul D., AFACAN ÖZTÜRK H. B., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.35, sa.3, ss.212-220, 2025 (SCI-Expanded, Scopus, TRDizin)

8. Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study

Sayin S., Kiliacslan E., YILDIRIM M., AFACAN ÖZTÜRK H. B., Safak Yilmaz E., ALBAYRAK M., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.24, sa.6, ss.1971-1977, 2023 (Scopus)

9. The Charlson Comorbidity Index Predicts Poor Prognosis in Elderly AML Patients

Tiglioglu M., ALBAYRAK M., Tiglioglu P., Yildiz A., Dogan S., AFACAN ÖZTÜRK H. B., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.1, ss.1-7, 2023 (SCI-Expanded, Scopus, TRDizin)

10. The prognostic significance of blood counts in patients with hodgkin lymphoma

Aras M., ALBAYRAK M., Yildiz A., Maral S., AFACAN ÖZTÜRK H. B., Tiglioglu P., et al.

Nigerian Journal of Clinical Practice , cilt.25, sa.8, ss.1332-1337, 2022 (SCI-Expanded, Scopus)

11. Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

Tığlıoğlu P., ALBAYRAK M., Yıldız A., Tığlıoğlu M., Sağlam B., Aras M. R., et al.

Journal of Hematopathology , cilt.15, sa.2, ss.83-93, 2022 (SCI-Expanded, Scopus)

12. Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment

Yılmaz F., ALBAYRAK M., Tığlıoğlu P., Tığlıoğlu M., Sağlam B., Reis Aras M., et al.

Journal of Oncology Pharmacy Practice , cilt.28, sa.3, ss.725-728, 2022 (SCI-Expanded, Scopus)

13. Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect

Tığlıoğlu M., Tığlıoğlu P., Yıldız A., Reis Aras M., Sağlam B., AFACAN ÖZTÜRK H. B., et al.

Journal of Clinical Pharmacy and Therapeutics , cilt.47, sa.4, ss.544-547, 2022 (SCI-Expanded, Scopus)

14. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Akpinar S., Dogu M. H., ÇELİK S., Ekinci O., Hindilerden I. Y., DAL M. S., et al.

Clinical Lymphoma, Myeloma and Leukemia , cilt.22, sa.3, ss.169-173, 2022 (SCI-Expanded, Scopus)

15. The outcome of COVID-19 in patients with hematological malignancy

Tığlıoğlu P., ALBAYRAK M., Tığlıoğlu M., AFACAN ÖZTÜRK H. B., Aras M. R., Sağlam B., et al.

Memo - Magazine of European Medical Oncology , cilt.15, sa.1, ss.83-89, 2022 (ESCI, Scopus)

16. Therapeutic Plasma Exchange in Neurological Disorders: A 9-year Experience

Aras M. R., Panpalli Ates M., ALBAYRAK M., AFACAN ÖZTÜRK H. B., Yildiz A., Yilmaz F., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.202-208, 2022 (SCI-Expanded, Scopus, TRDizin)

17. Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case

AFACAN ÖZTÜRK H. B., ALBAYRAK M., Maral S., Reis Aras M., Yilmaz F., Akyol P., et al.

Journal of Oncology Pharmacy Practice , cilt.27, sa.8, ss.2027-2029, 2021 (SCI-Expanded, Scopus)

18. Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis

Tığlıoğlu M., ALBAYRAK M., Doğan S., Yılmaz F., Akyol P., Sağlam B., et al.

Leukemia and Lymphoma , cilt.62, sa.11, ss.2755-2761, 2021 (SCI-Expanded, Scopus)

19. Analysis of Demographic and Clinical Characteristics of Primary Myelofibrosis and Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis Patients

Akyol P., Yıldız A., ALBAYRAK M., AFACAN ÖZTÜRK H. B., Maral S., Aras M. R., et al.

Gulhane Medical Journal , cilt.63, sa.2, ss.117-122, 2021 (Scopus, TRDizin)

20. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis

MALKAN Ü. Y., ALBAYRAK M., Yildiz A., Maral S., AFACAN ÖZTÜRK H. B., Comert P.

Journal of Oncology Pharmacy Practice , cilt.27, sa.1, ss.250-252, 2021 (SCI-Expanded, Scopus)

21. Thrombocytopenia due to rivaroxaban: A rare adverse effect

Tığlıoğlu M., Akyol P., Sağlam B., Aras M. R., AFACAN ÖZTÜRK H. B., Yıldız A., et al.

Transfusion and Apheresis Science , cilt.59, sa.6, 2020 (SCI-Expanded, Scopus)

22. A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

MALKAN Ü. Y., ALBAYRAK M., AFACAN ÖZTÜRK H. B., Reis Aras M., Saglam B., Dogan K.

Case Reports in Oncology , cilt.13, sa.3, ss.1368-1372, 2020 (ESCI, Scopus)

23. Primary Splenic Diffuse Large B Cell Lymphoma. Case Report and Literature Review

AFACAN ÖZTÜRK H. B., ALBAYRAK M., Pala Ç., Yıldız A., Maral S., Şahin O., et al.

SN Comprehensive Clinical Medicine , cilt.2, sa.11, ss.2448-2451, 2020 (Scopus)

24. Ibrutinib-induced polyneuropathy: A case report

Cömert P., ALBAYRAK M., Yıldız A., Şahin O., AFACAN ÖZTÜRK H. B., Reis Aras M.

Journal of Oncology Pharmacy Practice , cilt.26, sa.6, ss.1501-1504, 2020 (SCI-Expanded, Scopus)

25. Prognostic Value of Baseline Serum Lactate Dehydrogenase Level in Patients With Hairy Cell Leukemia

Maral S., ALBAYRAK M., DAĞDAŞ S., Yıldız A., Yıldırım R., Oz M., et al.

Clinical Lymphoma, Myeloma and Leukemia , cilt.20, sa.9, 2020 (SCI-Expanded, Scopus)

26. Diffuse large B cell lymphoma progression with skin involvement: A case report

Akyol P., ALBAYRAK M., Maral S., CANPOLAT F. E., AFACAN ÖZTÜRK H. B., Sağlam B., et al.

Journal of Tissue Viability , cilt.29, sa.3, ss.216-217, 2020 (SCI-Expanded, SSCI, Scopus)

27. A Rare Entity in Chronic Myelocytic Leukemia: Coexistence of BCR ABL1 Translocation and JAK2 V617F Mutation. Case Report

Sağlam B., ALBAYRAK M., Yıldız A., Akyol P., Öztürk Ç. P., Maral S., et al.

SN Comprehensive Clinical Medicine , cilt.2, sa.4, ss.478-480, 2020 (Scopus)

28. The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: A 9-year single-center experience

Yıldız A., ALBAYRAK M., Pala Ç., AFACAN ÖZTÜRK H. B., Maral S., Şahin O., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.2, ss.386-396, 2020 (SCI-Expanded, Scopus)

29. Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma

Cömert P., Yıldız A., YILDIRIM M., AFACAN ÖZTÜRK H. B., Pala Ç., ALBAYRAK M., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.36, sa.1, ss.78-83, 2020 (SCI-Expanded, Scopus)

30. Absolute lymphocyte count is a predictor of outcome after splenectomy for immune thrombocytopenia

Yildiz A., ALBAYRAK M., Pala Ç., Şahin O., Kuş A., Maral S., et al.

Gulhane Medical Journal , cilt.62, ss.103-108, 2020 (Scopus, TRDizin)

31. A first time report on the coocurrence of sarcoidosis and ALK(−) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment

AFACAN ÖZTÜRK H. B., ALBAYRAK M., Pala Öztürk Ç., Yıldız A., Maral S., ÖNDER E.

Journal of Oncology Pharmacy Practice , cilt.25, sa.7, ss.1801-1805, 2019 (SCI-Expanded, Scopus)

32. Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience

Yıldız A., AFACAN ÖZTÜRK H. B., ALBAYRAK M., Pala Ç., Şahin O., Maral S., et al.

Journal of Oncology Pharmacy Practice , cilt.25, sa.6, ss.1381-1387, 2019 (SCI-Expanded, Scopus)

33. An acute transverse myelitis attack after autologous stem cell transplantation: A rare case

Cömert P., ALBAYRAK M., Yıldız A., Şahin O., Öztürk Ç. P., Maral S., et al.

Transfusion and Apheresis Science , cilt.58, sa.3, ss.341-343, 2019 (SCI-Expanded, Scopus)

34. Refractory Thrombotic Thrombocytopenic Purpura in a patient with Kaposi sarcoma

Sahin O., ALBAYRAK M., Yıldız A., Pala Ç., Aktas L., Maral S., et al.

Transfusion and Apheresis Science , cilt.58, sa.2, ss.187-189, 2019 (SCI-Expanded, Scopus)

35. CD25 expression is associated with autoimmunity in patients with CLL KLL’li hastalarda CD25 ekspresyonu otoimmünite ile ilişkilidir

AFACAN ÖZTÜRK H. B., Yildiz A., ALBAYRAK M., Pala C., Maral S., Falay M.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.29, sa.3, ss.123-129, 2019 (SCI-Expanded, Scopus, TRDizin)

36. Effect of gibberellic acid on the levels of tumor necrosis factor-α, interleukin-4 and interleukin-10 in rats Sĩçanlarda gibberellik asitin tümör nekrozis faktör-α, interlökin-4 ve interlökin-10 düzeylerine etkisi

AFACAN ÖZTÜRK H. B., ERİN N., Balci M. K.

Turkish Journal of Endocrinology and Metabolism , cilt.23, sa.3, ss.150-157, 2019 (Scopus, TRDizin)

37. Infections in patients with lymphoma: An analysis of incidence, relationship and risk factors

Yıldız A., ALBAYRAK M., Pala Ç., Şahin O., AFACAN ÖZTÜRK H. B., Güneş G., et al.

Journal of Infection in Developing Countries , cilt.12, sa.9, ss.741-747, 2018 (SCI-Expanded, Scopus)

38. Rare aggressive natural killer cell leukemia presented with leukopenia and disseminated intravascular coagulation—a diagnostic challenge

Yıldız A., Şahin O., Öztürk Ç. P., AFACAN ÖZTÜRK H. B., Maral S., ALBAYRAK M.

Journal of Hematopathology , cilt.11, sa.1, ss.5-7, 2018 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Tez Danışmanlığı

Açık Erişim